225 related articles for article (PubMed ID: 16023804)
1. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI.
Hoffmann M; Hammar M; Kjellgren KI; Lindh-Astrand L; Brynhildsen J
Maturitas; 2005 Sep; 52(1):11-7. PubMed ID: 16023804
[TBL] [Abstract][Full Text] [Related]
2. Attitudes towards the menopause and hormone therapy over the turn of the century.
Lindh-Astrand L; Brynhildsen J; Hoffmann M; Liffner S; Hammar M
Maturitas; 2007 Jan; 56(1):12-20. PubMed ID: 16797891
[TBL] [Abstract][Full Text] [Related]
3. Patients' and clinicians' attitudes after the Women's Health Initiative study.
Blümel JE; Castelo-Branco C; Chedraui PA; Binfa L; Dowlani B; Gómez MS; Sarrá S
Menopause; 2004; 11(1):57-61. PubMed ID: 14716183
[TBL] [Abstract][Full Text] [Related]
4. After the Women's Health Initiative: decision making and trust of women taking hormone therapy.
Schonberg MA; Davis RB; Wee CC
Womens Health Issues; 2005; 15(4):187-95. PubMed ID: 16051110
[TBL] [Abstract][Full Text] [Related]
5. Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.
Barbaglia G; Macià F; Comas M; Sala M; del Mar Vernet M; Casamitjana M; Castells X
Menopause; 2009; 16(5):1061-4. PubMed ID: 19369903
[TBL] [Abstract][Full Text] [Related]
6. The impact of the Women's Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany.
Heitmann C; Greiser E; Dören M
Menopause; 2005; 12(4):405-11. PubMed ID: 16037755
[TBL] [Abstract][Full Text] [Related]
7. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
[TBL] [Abstract][Full Text] [Related]
8. Women's trust in and use of information sources in the treatment of menopausal symptoms.
Huston SA; Jackowski RM; Kirking DM
Womens Health Issues; 2009; 19(2):144-53. PubMed ID: 19272565
[TBL] [Abstract][Full Text] [Related]
9. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
Schonberg MA; Wee CC
J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005
[TBL] [Abstract][Full Text] [Related]
10. Women's use of hormone therapy before and after the Women's Health Initiative: a psychosocial model of stability and change.
Gerend MA; Aiken LS; Erchull MJ; Lapin A
Prev Med; 2006 Sep; 43(3):158-64. PubMed ID: 16750263
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
12. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era.
Nassar AH; Abd Essamad HM; Awwad JT; Khoury NG; Usta IM
Maturitas; 2005 Sep; 52(1):18-25. PubMed ID: 16143222
[TBL] [Abstract][Full Text] [Related]
13. Changing use of hormone therapy among minority women since the Women's Health Initiative.
Helenius IM; Korenstein D; Halm EA
Menopause; 2007; 14(2):216-22. PubMed ID: 17179789
[TBL] [Abstract][Full Text] [Related]
14. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
[TBL] [Abstract][Full Text] [Related]
15. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
[TBL] [Abstract][Full Text] [Related]
16. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
Naftolin F; Taylor HS; Karas R; Brinton E; Newman I; Clarkson TB; Mendelsohn M; Lobo RA; Judelson DR; Nachtigall LE; Heward CB; Hecht H; Jaff MR; Harman SM;
Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
[TBL] [Abstract][Full Text] [Related]
17. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
Parazzini F;
Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
[TBL] [Abstract][Full Text] [Related]
18. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
[TBL] [Abstract][Full Text] [Related]
19. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
Harman SM; Naftolin F; Brinton EA; Judelson DR
Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
[TBL] [Abstract][Full Text] [Related]
20. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
Barber CA; Margolis K; Luepker RV; Arnett DK
J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
